Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss - CNBC

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss - CNBC
4 stocks to watch on Friday: PM, PFE, MSTR, HIMS
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more - CNBC
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial - CNBC
137.76BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US7170811035
CUSIP
717081103
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
18.45
PEG Ratio
2.83
Book Value
15.81
Dividend Share
1.72
Dividend Yield
7.09%
Earnings Share
1.31
Wall Street Target Price
28.94
EPS Estimate Current Year
2.95
EPS Estimate Next Year
2.84
EPS Estimate Current Quarter
0.7217
EPS Estimate Next Quarter
0.6802
Most Recent Quarter
-
Revenue TTM
63,315,001,344
Gross Profit TTM
47,360,000,000
EBITDA
25,460,000,768
Profit Margin
11.83%
Return On Assets TTM
5.69%
Return On Equity TTM
8.31%
Revenue Per Share TTM
11.133
Qtly Revenue Growth YOY
5.40%
Diluted Eps TTM
1.31
Qtly Earnings Growth YOY
-10.10%
Trailing PE
18.45
Forward PE
8
Price Sales TTM
2.1757
Price Book MRQ
1.5289
Enterprise Value Revenue
2
Enterprise Value EBITDA
10
415.00
3.16%167.14
1.60%148.78
-3.17%248.26
-2.16%50.12
-0.75%243.25
-0.70%1149.01
-0.53%411.19
-0.50%120.78
-0.11%150.26
-0.07%Curated watchlists where PFE is featured.